Login / Signup

Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.

C Louwrens BraalAnne KleijburgAgnes JagerStijn L W KoolenRon H J MathijssenIsaac Corro RamosPim WetzelaerCarin A Uyl-de Groot
Published in: Clinical drug investigation (2022)
TDM-guided dose optimization of tamoxifen is estimated to save costs and increase QALYs for early breast cancer patients.
Keyphrases
  • early breast cancer
  • breast cancer cells
  • estrogen receptor
  • positive breast cancer
  • early stage
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • randomized controlled trial
  • open label
  • data analysis